ArticleCureus2025
Assessment of the Quality of Life of Saudi Patients in Pharmacist-Led Heart Failure Clinics: A Cross-Sectional Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimizing Heart Failure-Specific Disease Management Programs and Patient Care in Saudi Arabia: A Saudi Heart Association Position Statement.Journal of the Saudi Heart Association · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives Heart failure (HF) is a global health challenge with high morbidity and mortality, significantly impacting patients' quality of life (QOL). The QOL of Saudi patients, who were treated in the pharmacist-led HF clinics, is unknown. This study aims to evaluate HF patients' QOL using the validated Kansas City Cardiomyopathy Questionnaire (KCCQ-12). Methods A cross-sectional observational study was conducted with 111 randomly selected HF patients. QOL was assessed using the KCCQ-12, which encompasses domains evaluating physical limitations, HF-specific symptoms (swelling, shortness of breath (SOB), and fatigue), QOL, and social impact, with a score ranging from 0 (poorest health) to 100 (best health). The interpretation of health status is based on the overall summary KCCQ score as follows: very poor to poor (0-24), poor to fair (25-49), fair to good (50-74), and good to excellent (75-100). Results Overall, the highest score was in symptom frequency (82.7), indicating a few symptoms. The score for the dimension Social Limitation was 79.4, reflecting minimal social restrictions, while that for Physical Limitation was 71.7, indicating moderate physical activity limitations. The reported QOL score was 68.9, reflecting their fair to good QOL. The summary score was 75.4, reflecting an overall positive QOL assessment. The distribution of pharmacist interventions included the following: patient counseling was performed in 111 (100%) of cases, while the guideline-directed medical therapy (GDMT) monitoring follow-up was done for 58 (52.25%) of patients, and the initiation and titration of GDMT were conducted in 52 (46.85%) and 41 (36.94%) of cases, respectively. There is a weak positive correlation (rho=0.183) between the KCCQ-12 Summary Score and the total number of interventions received by patients, with a p-value of 0.056. This suggests a trend where an increased number of interventions may be associated with a slightly higher QOL, although this correlation is not statistically significant (p>0.05). Conclusion Based on the KCCQ findings, this study demonstrates the significant influence of clinical pharmacist interventions on the HF patient's QOL, which identifies the importance of HF clinics run by a cardiology clinical pharmacist within a multidisciplinary team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.